INBX - CIK 0001739614
Inhibrx, Inc. (INBX) reported revenue of $1.80M for fiscal year 2023, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2023 | $1.80M | -17.9% |
| FY 2022 | $2.19M | -69.7% |
| FY 2021 | $7.23M | -43.9% |
| FY 2020 | $12.89M | -2.4% |
| FY 2019 | $13.21M | - |
Between fiscal 2019 and fiscal 2023, Inhibrx, Inc.'s revenue declined from $13.21M to $1.80M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.